6β-methyl-3,20-dioxopregn-4-ene-17-yl acetate and its derivatives (for example, Megestrol acetate) are important progestines used for the treatment of endomentriosis as well as several other applications (Mishell, 1996).
The title compound, C 24 H 34 O 4 , is a precursor of Megestrol acetate. Ring A has a half-chair conformation [Q = 0.446 (3) Å , = 54.6 (4) and ' = 9.5 (4) ]. Ring D adopts a 13-envelope conformation [Q = 0.463 (2) Å and ' = 188. 2 (3) ].
Related literature
For the characterization of related structures, see: Evans & Boeyens (1989) . Soriano-Garcia et al. (2005) . Yousuf et al. (2011) . For the physiological properties of the title compound, see: Mishell (1996) .
Experimental
Crystal data (Farrugia, 1997) ; software used to prepare material for publication: WinGX (Farrugia, 1999) .
Figure 1
The molecular structure of (I) with displacement ellipsoids drawn at the 30% probability level. 
